Eli Lilly shares fell after orforglipron's Phase 3 data showed less weight loss than rival drugs, despite a strong Q2 ...

Lisa Bernett, from Boreham Wood in Hertfordhire, used to eat four bags of crisps a day, as well as two takeaways a week that ...

A mother-of-two left with saggy boobs and a 'turkey neck' after losing 3 stone on Mounjaro claims she now feels 'complete' ...

The experimental obesity medicine is one of two that could offer alternatives to weight-loss injections within the next year or so.

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...

Shares of Eli Lilly & Co. (LLY) were tumbling in early trading Thursday, after the drug giant disclosed late-stage trial data for its weight-loss pill that fell well short of expectations. The data ...

A new study shows that weight loss medication patients can experience hunger, eat well-balanced meals, and still make significant progress ...

Chief Executive David Ricks said the quarter was marked by robust sales for Zepbound and Mounjaro, in addition to momentum across other key medicines. Eli Lilly logged net income of $5.66 billion, or ...

A trial assessing a new daily pill for weight loss has shown that people taking the drug can shed kilos in weeks, potentially ...

Victoria Vigors is one of the many people using weight loss medication Mounjaro to shed the stubborn pounds. But after losing ...

Eli Lilly (LLY) stock plunges as Phase 3 trial data for the company's oral weight loss drug orforglipron overshadow better ...